Researchers have now developed an AI-based tool that is capable of detecting abnormalities of the coronary arteries in CT images with high precision. This tool could significantly prove beneficial for the diagnosis and treatment of rare heart diseases.
According to autopsy reports, up to 30 percent of unexpected deaths of young athletes can be attributed to coronary artery anomalies.
(Source: Pixabay)
Bern/Switzerland – Anomalous Aortic Origin of a Coronary Artery (AAOCA) are very rare congenital heart defects that are often overlooked by the untrained eye, but can have serious health consequences. They can lead to sudden cardiac death or heart attacks, especially in young, physically active people. According to autopsy reports, up to 30 percent of unexpected deaths of young athletes can be attributed to coronary artery anomalies. As they occur very rarely and often poorly understood in terms of their clinical significance - whether benign or potentially risky - coronary anomalies can be difficult to identify and classify. Improved diagnostics that allow such anomalies to be detected fully automatically could be life-saving for patients.
A research team led by Prof. Christoph Gräni, Professor at the University of Bern and Director of Cardiac Imaging at the Department of Cardiology at Inselspital Bern, and Dr. Isaac Shiri, Head of Research for Artificial Intelligence (AI) in Cardiovascular Medicine at Inselspital, in collaboration with the University Hospital Zurich, has now developed an innovative, fully automated tool based on AI that detects and classifies AAOCA in cardiac CT images. The study was recently published in the journal Nature Communications.
Leading Bern center for coronary anomalies
"As one of the leading centers for the assessment of coronary anomalies, patients from all over the world are referred to our university hospital. We therefore had a large amount of data from cardiac CT images at our disposal, which we were able to use to train the algorithm," says Christoph Gräni, last author of the study. A total of 4,128 CCTA images from 2,376 patients were analyzed, 335 of whom are affected by AAOCA. The tool developed uses a two-stage deep learning algorithm for segmentation and classification. The first step, image segmentation, separates the relevant anatomical structures from the surrounding tissues to provide a clear view of the coronary arteries. After image segmentation, the classification step focuses on detecting AAOCA cases and determining where the anomalous coronary vessel originates from in the aorta. The model was validated with external datasets in collaboration with the University Hospital Zurich and also tested on a publicly available dataset to ensure the robustness and reliability of the results.
High precision of the algorithm
"The AI-supported algorithm recognizes the cardiac malformations directly in the images and automatically determines the type of anomaly. The model showed a surprisingly high level of precision and was even able to identify borderline cases where even experts disagreed. This high accuracy underlines the potential of the tool to be seamlessly integrated into clinical workflows," explains Gräni. For example, the tool could provide real-time alerts for potentially high-risk AAOCA abnormalities and support imaging specialists in clinical diagnosis. The tool also enables large population-based image datasets to be searched specifically for coronary anomalies and their correlation with the clinical outcome to be analyzed. "Analyzing such rare diseases in large retrospective and prospective cohorts of images is too time-consuming manually, but precisely such studies are absolutely essential for improved risk stratification," says Gräni.
Close collaboration in the field of digital medicine
This work is an example of the direct impact digital medicine can have on improving patient care and the importance of close collaboration between the University of Bern and Inselspital in the development of AI applications in medicine. Advancing digitalization in medicine is a long-term strategic goal of the University of Bern's Faculty of Medicine and is closely aligned with the University of Bern's overarching digitalization strategy.
Further studies are needed to refine the model and test it in real clinical environments. Gräni's team is now developing a digital artificial twin for coronary anomalies together with the research group of Prof. Dr. Dominik Obrist from the Cardiovascular Engineering research group at the Artorg Center for Biomedical Engineering Research. This requires important data from interventional measurements, which are collected in collaboration with Prof. Lorenz Räber, Head of the Heart Catheter Laboratory at Inselspital. This approach should help to assess the relevance of a coronary anomaly with the help of a digital and physical twin outside the patient - for example under simulated sports conditions - to avoid interventional examinations and better assess the risk. "This digital twin technology could be extended to other rare cardiovascular anomalies and transform cardiology diagnostics as a whole," concludes Gräni.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.